Event - Best practice meeting - Breast Cancer (WP1.3)

EuroGentest and the European Molecular Genetics Quality Network In association with the Canadian CanGeneTest network and the International Federation of Clinical Chemistry are pleased to announce this meeting to develop best practice guidelines for clinical molecular genetic testing . EuroGentest/EMQN will fund travel and accomodation for a limited number of invited experts from EU or non EU countries and a maximum of one delegate from each European Union Country.

Delegates representing non EU countries must be self funded. The mechanism for selecting delegates will be announced shortly but they must have a sound knowledge and experience in the relevant diagnostic area. In addition delegates must be able to represent the relevant molecular genetic diagnostic community in their country and be prepared to report back to that community preferably through a national level meeting to discuss the draft guidelines.